Pharmacokinetics and tolerability of three ordopidine dose levels in volunteers

Trial Profile

Pharmacokinetics and tolerability of three ordopidine dose levels in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Jun 2008

At a glance

  • Drugs Ordopidine (Primary)
  • Indications Bipolar disorders; Parkinson's disease
  • Focus Pharmacokinetics
  • Sponsors NeuroSearch
  • Most Recent Events

    • 26 Jun 2008 Status changed from in progress to completed, according to a NeuroSearch media release (9090561).
    • 10 Nov 2006 The expected completion date for this trial is now 30 Jun 2007.
    • 10 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top